We are live on ! Find out more
AllianceBernstein

AllianceBernstein Portfolio holdings

AUM $309B
1-Year Est. Return 23.92%
 

AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.

This Fund
S&P 500
This Quarter Est. Return
+5.78%
1 Year Est. Return
+23.92%
3 Year Est. Return
+92.38%
5 Year Est. Return
+118.97%
10 Year Est. Return
+515.32%
AUM
$118B
AUM Growth
+$2.37B
Cap. Flow
-$2.87B
Cap. Flow %
-2.42%
Top 10 Hldgs %
14.37%
Holding
3,058
New
95
Increased
1,049
Reduced
1,331
Closed
82

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$274M
2
MSFT icon
Microsoft
MSFT
+$263M
3
CMCSA icon
Comcast
CMCSA
+$248M
4
APH icon
Amphenol
APH
+$238M
5
ELV icon
Elevance Health
ELV
+$238M

Sector Composition

Rank Sector Weight
1 Technology 15.59%
2 Financials 14.66%
3 Healthcare 14.25%
4 Consumer Discretionary 10.15%
5 Industrials 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANIK icon
2276
Anika Therapeutics
ANIK
$199M
$885K ﹤0.01%
18,500
-21,330
-54% -$1.05M
CHRS icon
2277
Coherus Oncology
CHRS
$217M
$882K ﹤0.01%
32,920
CFNB
2278
DELISTED
California First National Banc
CFNB
$882K ﹤0.01%
63,189
-5,403
-8% -$79.4K
FBR
2279
DELISTED
Fibria Celulose Sa
FBR
$879K ﹤0.01%
124,293
+5,539
+5% +$36.7K
DHIL
2280
DELISTED
Diamond Hill
DHIL
$877K ﹤0.01%
4,745
-100
-2% -$19K
HSTM icon
2281
HealthStream
HSTM
$793M
$876K ﹤0.01%
31,740
-900
-3% -$23.3K
PLAB icon
2282
Photronics
PLAB
$1.79B
$874K ﹤0.01%
84,800
-1,300
-2% -$12.5K
ATW
2283
DELISTED
Atwood Oceanics
ATW
$873K ﹤0.01%
100,500
WMK icon
2284
Weis Markets
WMK
$1.82B
$872K ﹤0.01%
16,454
-300
-2% -$15.6K
USCR
2285
DELISTED
U S Concrete, Inc.
USCR
$871K ﹤0.01%
18,900
BRS
2286
DELISTED
Bristow Group, Inc.
BRS
$870K ﹤0.01%
62,048
HY icon
2287
Hyster-Yale Materials Handling
HY
$593M
$868K ﹤0.01%
14,436
-900
-6% -$51K
SIMO icon
2288
Silicon Motion
SIMO
$9.19B
$866K ﹤0.01%
+16,730
New +$872K
SUP
2289
DELISTED
Superior Industries International
SUP
$849K ﹤0.01%
29,120
RATE
2290
DELISTED
Bankrate Inc
RATE
$846K ﹤0.01%
99,780
-5,700
-5% -$45.3K
CASS icon
2291
Cass Information Systems
CASS
$698M
$844K ﹤0.01%
19,669
NX icon
2292
Quanex
NX
$854M
$844K ﹤0.01%
48,922
ITCI
2293
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$844K ﹤0.01%
55,410
EPE
2294
DELISTED
EP Energy Corporation
EPE
$844K ﹤0.01%
192,762
+13,200
+7% +$55.1K
CHH icon
2295
Choice Hotels
CHH
$5.03B
$841K ﹤0.01%
18,665
-200
-1% -$9.6K
HRTX icon
2296
Heron Therapeutics
HRTX
$86.3M
$839K ﹤0.01%
48,700
+1,300
+3% +$24.1K
ANAT
2297
DELISTED
American National Group, Inc. Common Stock
ANAT
$836K ﹤0.01%
6,854
DO
2298
DELISTED
Diamond Offshore Drilling
DO
$835K ﹤0.01%
47,402
-65,312
-58% -$1.31M
HTO
2299
H2O America
HTO
$2.67B
$834K ﹤0.01%
19,100
GTN icon
2300
Gray Television
GTN
$407M
$833K ﹤0.01%
80,400

Similar funds

AllianceBernstein's Q3 2016 Portfolio in Review

As of Q3 2016, AllianceBernstein held 3,058 positions worth $118B, up 2% from $116B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

AllianceBernstein's Q3 2016 filing shows 95 new, 1,049 increased, 1,331 reduced and 82 closed positions. Its largest new stake was Teva Pharmaceuticals: 2,294,681 shares worth $106M. The largest sale was Pfizer, an estimated $274M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • AllianceBernstein's largest Q3 2016 buy was Teva Pharmaceuticals: 2,294,681 shares worth $106M.
  • AllianceBernstein added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $567M increase.
  • AllianceBernstein's biggest Q3 2016 reduction was Pfizer, cutting an estimated $274M.
  • AllianceBernstein fully exited EMC CORPORATION in Q3 2016, selling an estimated $99.6M.
  • AllianceBernstein's ten largest holdings make up 14% of its $118B portfolio in Q3 2016.
  • AllianceBernstein opened 95 new positions and closed 82 in Q3 2016.
  • AllianceBernstein's portfolio value rose 2% quarter-over-quarter to $118B.

Based on AllianceBernstein's 13F filing for Q3 2016, filed 10 Nov 2016.